| 61 |
|
PERSPECTIVES IN PHARMACOLOGY - Critical Role for Nitric Oxide Signaling in Cardiac and Neuronal Ischemic Preconditioning and Tolerance/
|
Nandagopal, Krishnadas
|
Williams & Wilkins
|
2001
|
|
|
|
| 62 |
|
PERSPECTIVES IN PHARMACOLOGY - Drug Synergism: Its Detection and Applications/
|
Tallarida, Ronald J
|
Williams & Wilkins
|
2001
|
|
|
|
| 63 |
|
PERSPECTIVES IN PHARMACOLOGY - Estrogenic Actions in the Brain: Estrogen, Phytoestrogens, and Rapid Intracellular Signaling Mechanisms/
|
Belcher, Scott M
|
Williams & Wilkins
|
2001
|
|
|
|
| 64 |
|
PERSPECTIVES IN PHARMACOLOGY - Growth Factor Signaling in Cell Survival: Implications for Cancer Treatment/
|
Talapatra, Sunit
|
Williams & Wilkins
|
2001
|
|
|
|
| 65 |
|
PERSPECTIVES IN PHARMACOLOGY - Improving the Treatment of Schizophrenia: Focus on Serotonin (5-HT)IA Receptors/
|
Millan, Mark J
|
Williams & Wilkins
|
2001
|
|
|
|
| 66 |
|
PERSPECTIVES IN PHARMACOLOGY - Mechanisms of Endocannabinoid Inactivation: Biochemistry and Pharmacology/
|
Giuffrida, Andrea
|
Williams & Wilkins
|
2001
|
|
|
|
| 67 |
|
PERSPECTIVES IN PHARMACOLOGY - Molecular Mechanisms of Selective Estrogen Receptor Modulator (SERM) Action/
|
Dutertre, Martin
|
Williams & Wilkins
|
2000
|
|
|
|
| 68 |
|
PERSPECTIVES IN PHARMACOLOGY - Multiple Central Nervous System Targets for Eliciting Beneficial Effects on Memory and Cognition/
|
Buccafusco, Jerry J
|
Williams & Wilkins
|
2000
|
|
|
|
| 69 |
|
PERSPECTIVES IN PHARMACOLOGY - P2 Purinergic Receptors: Modulation of Cell Function and Therapeutic Potential/
|
Burnstock, Geoffrey
|
Williams & Wilkins
|
2001
|
|
|
|
| 70 |
|
PERSPECTIVES IN PHARMACOLOGY - Pharmacology of Opioid and Nonopioid Analgesics in Chronic Pain States/
|
Martin, Thomas J
|
Williams & Wilkins
|
2001
|
|
|
|
| 71 |
|
PERSPECTIVES IN PHARMACOLOGY - Phospholipase A2s in Cell Injury and Death/
|
Cummings, Brian S
|
Williams & Wilkins
|
2000
|
|
|
|
| 72 |
|
PERSPECTIVES IN PHARMACOLOGY - Post-Translational Control of Endothelial Nitric Oxide Synthase: Why Isn't Calcium/Calmodulin Enough?/
|
Fulton, David
|
Williams & Wilkins
|
2001
|
|
|
|
| 73 |
|
PERSPECTIVES IN PHARMACOLOGY - Regulation of Adult Neurogenesis by Psychotropic Drugs and Stress/
|
Duman, Ronald S
|
Williams & Wilkins
|
2001
|
|
|
|
| 74 |
|
PERSPECTIVES IN PHARMACOLOGY - Regulator of G Protein Signaling Proteins: Novel Multifunctional Drug Targets/
|
Zhong, Huailing
|
Williams & Wilkins
|
2001
|
|
|
|
| 75 |
|
PERSPECTIVES IN PHARMACOLOGY - Review of Mammalian DNA Repair and Translational Implications/
|
Hansen, W Kent
|
Williams & Wilkins
|
2000
|
|
|
|
| 76 |
|
PERSPECTIVES IN PHARMACOLOGY - The Biochemical and Neurologic Basis for the Treatment of Male Erectile Dysfunction/
|
Moreland, Robert B
|
Williams & Wilkins
|
2001
|
|
|
|
| 77 |
|
PERSPECTIVES IN PHARMACOLOGY - The Dopamine, Transporter and Cocaine Medication Development: Drug Self-Administration in Nonhuman Primates/
|
Howell, Leonard L
|
Williams & Wilkins
|
2001
|
|
|
|
| 78 |
|
PERSPECTIVES IN PHARMACOLOGY - The Role of Time as a Quantifiable Variable of Toxicity and the Experimental Conditions When Haber's c x t Product Can Be Observed: Implications for Therapeutics/
|
Rozman, Karl K
|
Williams & Wilkins
|
2001
|
|
|
|
| 79 |
|
PERSPECTIVES IN PHARMACOLOGY - Transgenic Studies of Pain and Analgesia: Mutation or Background Genotype?/
|
Lariviere, William R
|
Williams & Wilkins
|
2001
|
|
|
|
| 80 |
|
PERSPECTIVES IN PHARMACOLOGY - Unifying Perspectives of the Mechanisms Underlying the Development of Tolerance and Physical Dependence to Opioids/
|
Taylor, David A
|
Williams & Wilkins
|
2001
|
|
|
|